iPLATO Innovation Improves Patient Access to GP Services

iPLATO HealthcareiPLATO Healthcare, a UK leader in cloud based mHealth and Analytics, has launched a new feature which allows patients to automatically cancel GP appointments via their mobile phone without intervention by reception staff at the practice. This new iPLATO feature - available for Enterprise and Pro users - will further reduce the practice workload related to appointment management and improve patient access to GP services.

Early users of automated cancellations are excited about the possibilities of this new feature. "Whilst eliminating effort for practice staff to deal with incoming cancellation requests from patients, this new feature has significantly sped up the process of making short term appointments available for other patients" says Lesley Kenny, Practice Manager and trial practice at The Hammersmith Surgery. "The reception team find it extremely efficient as freed up appointments can be given to someone else phoning in. I strongly urge all iPLATO users to trial 'automated cancellations' and not miss out!"

"Automated appointment cancellations is part of a broader feature set that aims to update the practice's GP System automatically based on incoming messages from patients" says Tobias Alpsten, CEO of iPLATO Healthcare. "The new iPLATO feature recognises 'Keywords' so, when a patient sends a Keyword such as 'CANCEL' as a reply to an appointment reminder, the appointment is automatically removed from the GP System and the practice reception are notified via e-mail. This new feature improves patient services and reduces the administrational burden for practices to manage appointments."

"Improved access to GP services reduces pressure on A&E" adds Alpsten. "In addition to improved access to GP services the Keyword feature will lead to long term outcomes such as reduced workload for reaching QoF targets and reduced pressure on switchboards.

Overall it's a win-win-win for our commissioners, practices and patients!"

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company. iPLATO’s evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...